John Dailey possesses extensive experience within the biopharmaceutical industry, currently serving as MA V at Biogen since November 2022. Prior to this role, John held the position of Operations Lead Downstream Purification at Merck from December 2021 to November 2022. John also has a significant tenure at FUJIFILM Diosynth Biotechnologies, where responsibilities included serving as Shift Lead from February 2015 to October 2021. Earlier experience includes a role as Lead Production Tech I at DIOSYNTH BIOTECHNOLOGY from March 2007 to February 2015 and as a Manufacturing Associate at Biogen from 2003 to 2004.
This person is not in any teams
This person is not in any offices